These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2553195)

  • 21. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate].
    Morimoto S
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of the effects of pyruvate and CG-120 in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Tanaka T; Morozumi M
    Hinyokika Kiyo; 1986 Sep; 32(9):1341-7. PubMed ID: 3812152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of urine alkalization on excretion of renal citrate and degree of urine saturation with calcium oxalate in patients with calcium-oxalate urolithiasis and in healthy subjects].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Feb; 91(2):77-83. PubMed ID: 8008619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.
    Allie-Hamdulay S; Rodgers AL
    Urol Res; 2005 May; 33(2):116-24. PubMed ID: 15871014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.
    Zerwekh JE; Hwang TI; Poindexter J; Hill K; Wendell G; Pak CY
    Kidney Int; 1988 May; 33(5):1005-8. PubMed ID: 3134570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of the urinary risk factors of urolithiasis with magnesium and tartrate mixture: a new treatment.
    Hallson PC; Rose GA
    Br J Urol; 1988 May; 61(5):382-4. PubMed ID: 3395794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.